Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19
Background. Coronavirus disease 2019 (COVID-19) is a pandemic of the new millennium. COVID-19 can cause both pulmonary and systemic infammation, and can rapidly progress to multiple organ failure. Data on the relationship between COVID-19 and the thyroid gland have been available since March 2020. T...
Main Author: | E. V. Ryabchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2022-06-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/2175 |
Similar Items
-
SPORADIC MEDULLARY THYROID CANCER. СASE REPORT
by: L. A. Ivanova, et al.
Published: (2015-04-01) -
PREVENTIVE CENTRAL LYMPHADENECTOMY IS THE SAFE SURGERY METHOD OF CHOICE IN PATIENTS WITH THYROID CANCER
by: A. F. Romanchishen, et al.
Published: (2015-04-01) -
Calcitonin testing in patients with thyroid nodules for screening medullary thyroid carcinoma: a “gray zone”
by: N. V. Severskaya, et al.
Published: (2022-08-01) -
Possibilities of single photon emission tomography in the diagnosis of bone metastases in patients with disseminated medullary thyroid carcinoma (case report)
by: E. E. Stanyakina, et al.
Published: (2019-07-01) -
Significance of laboratory markers in the diagnosis and postoperative monitoring of patients with medullary thyroid cancer
by: L. A. Ivanova, et al.
Published: (2014-10-01)